mibavademab tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity Model News: zepbound causes more weight

Methods The Peptide Innovation for Early Diabetes Treatment (PIONEER) 11 trial was a double-blind, randomised, Phase IIIa trial conducted across 52 sites in the China region (mainland China and Taiwan), Hungary, Serbia and Ukraine

This article explores the current status of oral GLP-1 drugs, what they mean for diabetes care, and how they may change the treatment landscape

Among the participants, 15,264 females (13.7%) had documented prescriptions for GLP-1 medications and 96,382 women (86.3%) had no documented exposure to GLP-1 drugs

Sleep Is the New Stress Indicator Sleep is no longer nice to have its become a health KPI